Biocon stock surges over 8% on the BSE
DSIJ Intelligence / 12 Jul 2017
In the early morning trade on Wednesday, the stock of Biocon Ltd. surged over 8% on the BSE, ahead of the USFDA meet to discuss its breast cancer drug filing.
In the early morning trade on Wednesday,the stock of Biocon Ltd. surged over 8% on the BSE, ahead of the USFDA meet to discuss its breast cancer drug filing.
The US drug regulator’s Advisory Committee (Adcom) will be meeting on July 13 to discuss trastuzumab filing done by Mylan, Biocon’s partner.
Biocon Ltd. was trading at Rs 342.45, up by Rs 19.35 or 5.99% as at 1034 hours on Wednesday, on the BSE. The stock had hit an intraday high of Rs 351.10.
The Indian biopharma giant, had plunged over 9% during Monday’s trade on the BSE as the French inspecting authority (ANSM) found lapses at Biocon's Bengaluru plant.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.